Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mark Adams, Teri Willey, Zunyan Dai, Daniel Sharer, Patricia Hall, More

Premium

Good Start Genetics has appointed Mark Adams to Chief Information Officer. Adams joins Good Start from Bridgewater Associates and was previously a principal with Booz Allen Hamilton, where he developed a biomedical informatics consulting practice. He has also been vice president of bioinformatics at Variagenics, and held positions at Incyte. He holds a BA from Oberlin College and a PhD from Baylor College of Medicine.


Cold Spring Harbor Laboratory has appointed Teri Willey to VP of Business Development & Technology Transfer, where she will direct the laboratory's commercialization and technology transfer activities including patenting, licensing, company start-ups, and corporate partnerships and collaborations. She is taking over for John Maroney, who will continue in his role as general counsel.

Willey joins CSHL from Mount Sinai Medical Center, and was also Founding Executive Director of Cambridge Enterprise. She has also served as an advisor to Congress and is a past President of the Association of University Technology Managers.


Emory Genetics Laboratory has hired five new directors that will join full-time within the next month. Zunyan Dai has joined EGL from Quest and will serve as Director, Cytogenetics Laboratory. Daniel Sharer from the University of Alabama at Birmingham and Patricia Hall from the Mayo Clinic will both serve as Director, Biochemical Genetics Laboratory. John Alexander from the University of Alabama at Birmingham; Yuan Xue from the University of California, Los Angeles; and Alice Tanner, a board certified genetic counselor at Emory, will all serve as Director, Molecular Genetics Laboratory.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.